Responsibilities of Data Monitoring Committees: Consensus Recommendations

被引:7
|
作者
Bierer, Barbara E. [1 ,2 ,3 ,4 ]
Li, Rebecca [1 ,2 ,3 ,4 ]
Seltzer, Jonathan [5 ]
Sleeper, Lynn A. [6 ]
Frank, Elizabeth [7 ]
Knirsch, Charles [8 ]
Aldinger, Carmen E. [3 ,4 ]
Levine, Robert J. [9 ]
Massaro, Joe [10 ]
Shah, Amish [11 ]
Barnes, Mark [3 ,4 ,11 ]
Snapinn, Steven [12 ]
Wittes, Janet [13 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
[3] Brigham & Womens Hosp, Multireg Clin Trials Ctr, 14 Story St,4th Floor, Cambridge, MA 02138 USA
[4] Harvard, 14 Story St,4th Floor, Cambridge, MA 02138 USA
[5] ACI Clin, Bala Cynwyd, PA USA
[6] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Pfizer, New York, NY USA
[9] Yale Univ, New Haven, CT USA
[10] Boston Univ, Boston, MA 02215 USA
[11] Ropes & Gray, Boston, MA USA
[12] Amgen Inc, Thousand Oaks, CA USA
[13] Stat Collaborat Inc, Washington, DC USA
关键词
safety data; clinical trials; oversight of clinical trials; human subject safety; multi-site clinical trials; Data Monitoring Committees;
D O I
10.1177/2168479016646812
中图分类号
R-058 [];
学科分类号
摘要
Background: A data monitoring committee (DMC) has special responsibilities for protecting the safety of clinical trial participants. Few guidance documents are available that address the operations and mechanics of establishing, serving on, or reporting to a DMC. This article provides a practical guide to sponsors, institutions, and individuals responsible for, or serving on, a DMC. Methods: A workgroup of professionals from academia and not-for-profit and commercial organizations that included investigators, statisticians, patient advocates, and ethicists met to define the essential elements of planning, coordinating, and populating a DMC. All members of the group have formed, served on, advised, or worked with DMCs. Results: The group outlined the objectives and mechanics of running a DMC, including operational and practical considerations, membership characteristics, roles, members' liability, and indemnification. Further, it delineated the roles and responsibilities of each DMC member. Conclusions: The group recommended practices for each phase of the DMC process from inception through execution of a clinical trial, with appropriate considerations for confidentiality. The group's practical guidance should assist in comprehensive oversight of appropriate clinical trials and should help DMC members execute their obligations with greater assurance.
引用
收藏
页码:648 / 659
页数:12
相关论文
共 50 条
  • [1] Responsibilities of Data Monitoring Committees: Consensus Recommendations
    Barbara E. Bierer
    Rebecca Li
    Jonathan Seltzer
    Lynn A. Sleeper
    Elizabeth Frank
    Charles Knirsch
    Carmen E. Aldinger
    Robert J. Levine
    Joe Massaro
    Amish Shah
    Mark Barnes
    Steven Snapinn
    Janet Wittes
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 648 - 659
  • [2] Data sharing among data monitoring committees and responsibilities to patients and science
    Chalmers, Iain
    Altman, Douglas G.
    McHaffie, Hazel
    Owens, Nancy
    Cooke, Richard W. I.
    TRIALS, 2013, 14
  • [3] Data sharing among data monitoring committees and responsibilities to patients and science
    Iain Chalmers
    Douglas G Altman
    Hazel McHaffie
    Nancy Owens
    Richard WI Cooke
    Trials, 14
  • [4] The Many Moral Responsibilities of Independent Data-Monitoring Committees
    Braillon, Alain
    AMERICAN JOURNAL OF BIOETHICS, 2011, 11 (03): : 16 - 17
  • [5] Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative
    Calis, Karim A.
    Archdeacon, Patrick
    Bain, Raymond
    DeMets, David
    Donohue, Miriam
    Elzarrad, M. Khair
    Forrest, Annemarie
    McEachern, John
    Pencina, Michael J.
    Perlmutter, Jane
    Lewis, Roger J.
    CLINICAL TRIALS, 2017, 14 (04) : 342 - 348
  • [6] Data Monitoring Committees
    Novack, Gary D.
    OCULAR SURFACE, 2010, 8 (01): : 40 - 43
  • [7] Enhancing the Scientific Integrity and Safety of Clinical Trials Recommendations for Data Monitoring Committees
    Lewis, Roger J.
    Calis, Karim A.
    DeMets, David L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (22): : 2359 - 2360
  • [8] CONSENSUS RECOMMENDATIONS ON EFFECTIVE INSTITUTIONAL ANIMAL CARE AND USE COMMITTEES
    不详
    LABORATORY ANIMAL SCIENCE, 1987, 37 : 11 - 13
  • [9] Data monitoring committees and interim monitoring guidelines
    Freidlin, B
    Korn, EL
    George, SL
    CONTROLLED CLINICAL TRIALS, 1999, 20 (05): : 395 - 407
  • [10] Consensus and recommendations on continuous glucose monitoring
    Chawla, Manoj
    Saboo, Banshi
    Jha, Sujeet
    Bhandari, Sudhir
    Kumar, Prasanna
    Kesavadev, Jothydev
    Munjal, Yash Pal
    Mohan, Viswanathan
    Unnikrishnan, Ranjit
    Katswar, Vishal
    Arun, Nanditha
    Sosale, Bhavana
    Anjana, Ranjit Mohan
    Hasnani, Dhruvi
    JOURNAL OF DIABETOLOGY, 2019, 10 (01) : 4 - 14